Cole, president of Investor Relations Advisory Solutions LLC in Broomfield, takes over chairman duties from Steve Orndorff, chief executive of Broomfield-based Ariel Pharmaceuticals Inc.
Cole has 22 years of experience in the capital-markets and corporate-planning sectors. He has 16 years of dedicated investor relations, corporate communications and media relations experience focused on supporting the development of private, small- and mid-cap companies.
New officers on the board include vice chairman Mark Spiecker, CEO, Sharklet Technologies Inc. in Aurora; treasurer Jim Wilson, partner, Ernst & Young in Denver; and secretary Lisa Drake, director of government affairs for Monsanto Co. in Englewood.
New board members include Bill Marshall, president and CEO of miRagen Inc. in Boulder; Chris Myatt, co-founder and CEO of MBio Diagnostics Inc. in Boulder; Bob Reddy, director of global marketing, Medtronic Navigation Inc. in Louisville; Brenda Fielding, executive vice president of regulatory and strategic development at Clinipace Worldwide in Boulder; Scott Larson, senior vice president of Terumo BCT in Lakewood; and Brett Lund, executive vice president of Gevo Inc. in Englewood.